AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 179 filers reported holding AXSOME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,805 | +39.3% | 40,130 | +43.2% | 0.02% | +41.7% |
Q2 2023 | $2,014 | +100600.0% | 28,026 | +93320.0% | 0.01% | – |
Q1 2023 | $2 | 0.0% | 30 | 0.0% | 0.00% | – |
Q4 2022 | $2 | -99.8% | 30 | +50.0% | 0.00% | – |
Q3 2022 | $1,000 | 0.0% | 20 | 0.0% | 0.00% | – |
Q2 2022 | $1,000 | 0.0% | 20 | -31.0% | 0.00% | – |
Q1 2022 | $1,000 | -66.7% | 29 | -68.1% | 0.00% | – |
Q4 2021 | $3,000 | -100.0% | 91 | -99.9% | 0.00% | -100.0% |
Q2 2021 | $6,167,000 | 0.0% | 91,417 | 0.0% | 0.05% | 0.0% |
Q1 2021 | $6,167,000 | 0.0% | 91,417 | 0.0% | 0.05% | 0.0% |
Q4 2020 | $6,167,000 | 0.0% | 91,417 | 0.0% | 0.05% | 0.0% |
Q3 2020 | $6,167,000 | 0.0% | 91,417 | 0.0% | 0.05% | 0.0% |
Q2 2020 | $6,167,000 | 0.0% | 91,417 | 0.0% | 0.05% | 0.0% |
Q1 2020 | $6,167,000 | 0.0% | 91,417 | 0.0% | 0.05% | 0.0% |
Q4 2019 | $6,167,000 | 0.0% | 91,417 | 0.0% | 0.05% | 0.0% |
Q3 2019 | $6,167,000 | 0.0% | 91,417 | 0.0% | 0.05% | 0.0% |
Q2 2019 | $6,167,000 | 0.0% | 91,417 | 0.0% | 0.05% | 0.0% |
Q1 2019 | $6,167,000 | – | 91,417 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 758,794 | $53,032,113 | 65.14% |
Fairmount Funds Management LLC | 2,341,238 | $163,629,124 | 19.69% |
Ally Bridge Group (NY) LLC | 110,600 | $7,729,834 | 9.07% |
RTW INVESTMENTS, LP | 4,489,596 | $313,777,864 | 6.62% |
SVB FINANCIAL GROUP | 33,849 | $2,365,707 | 4.45% |
BVF INC/IL | 2,131,100 | $148,942,579 | 4.02% |
Altium Capital Management LP | 92,000 | $6,429,880 | 3.35% |
Tri Locum Partners LP | 142,510 | $9,960,024 | 3.18% |
TANG CAPITAL MANAGEMENT LLC | 320,000 | $22,364,800 | 3.16% |
Deep Track Capital, LP | 1,140,745 | $79,726,668 | 3.08% |